Brief: Sensorion Receives European Medicines Agency Agreement On Pediatric Investigation Plan For Arazasetron In Two Indications

Sensorion SA

28/06/2019 06:34

June 28 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION RECEIVES EUROPEAN MEDICINES AGENCY AGREEMENT ON
THE
PEDIATRIC INVESTIGATION PLAN (PIP) FOR ARAZASETRON (SENS-401) IN
TWO INDICATIONS
    * THIS AGREEMENT PAVES WAY FOR SUBMISSION OF A MARKETING
AUTHORIZATION APPLICATION IN EUROPE
    * INTERIM SAFETY RESULTS ARE EXPECTED AT END OF 2019
    * THIS DATA ON OTOPROTECTION AND RECOVERY OF AUDITORY
CAPACITY
CONFIRMS PROMISING CLINICAL POTENTIAL OF SENS-401 IN SUDDEN
ONSET DEAFNESS

Source text for Eikon:  ID:nBw8KP3lZa 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))